Patents Assigned to PARI Pharma GmbH
-
Patent number: 10744277Abstract: An aerosol delivery device includes an aerosol generator for generating an aerosol in the aerosol delivery device with a membrane and a vibrator which is configured to vibrate a fluid and to aerosolise the fluid by the membrane. The aerosol delivery device further includes a fluid reservoir for receiving the fluid to be aerosolised, the fluid reservoir being arranged in fluid communication with the membrane, a controller which is configured to sequentially operate the vibrator at a plurality of different vibration frequencies, a sensor which is configured to detect at least one electrical parameter of the vibrator for each of the plurality of different vibration frequencies, and a detector which is configured to detect the presence of fluid in contact with the membrane and/or in the fluid reservoir on the basis of the dependence of the detected values of the at least one electrical parameter on the vibration frequency.Type: GrantFiled: December 15, 2014Date of Patent: August 18, 2020Assignee: PARI Pharma GmbHInventors: Matthias Finke, Dominique Mutschmann, Wolfgang Achtzehner, Philipp Holzmann
-
Patent number: 10688518Abstract: The invention relates to a method of manufacturing a vibratable head (1) for an aerosol generator (2), the vibratable head (1) comprising a support member (4), a vibratable membrane (6) supported by the support member (4) and a vibrator (8) configured to vibrate the vibratable membrane (6). The method comprises the steps of providing the support member (4), roughening a surface portion (10) of the support member (4) by laser structuring, applying an adhesive (9) to at least a part of the roughened surface portion (10) of the support member (4) and attaching at least one element to the support member (4) by at least a portion of the adhesive (9). Further, the invention relates to a vibratable head (1) manufactured by this method, an aerosol generator (2) comprising such a vibratable head (1) and a method of manufacturing such an aerosol generator (2).Type: GrantFiled: August 3, 2016Date of Patent: June 23, 2020Assignee: PARI Pharma GmbHInventors: Hans-Lukas Anzenberger, Nicole Brune, Durdica Benko
-
Publication number: 20200193806Abstract: The present invention relates to a control device for controlling an operation of an aerosol nebulizer system (30), said aerosol nebulizer system (30) comprising an aerosol generator (31) for nebulizing a liquid and a plurality of sensor units (38a, 38b, 38c, 38d, 38e), said control device (20) comprising: a communication unit (21), configured to establish a wireless communication connection and to perform data transmission with the aerosol nebulizer system (30), a sensor data control unit (22), configured to trigger a selection of sensor data related to the sensor units (38a, 38b, 38c, 38d, 38e) to be wirelessly transmitted to the control device (20).Type: ApplicationFiled: March 16, 2018Publication date: June 18, 2020Applicant: PARI Pharma GmbHInventors: Matthias Finke, Carola Fuchs, Björn Eschrich, Edgard Osswald, Philipp Kroneberg, Michael Hahn, Ingo Schraut, Sascha Roeder
-
Publication number: 20200155772Abstract: Inhalator comprising an aerosol generator configured to generate an aerosol by nebulizing a fluid and a controller configured to control operation of the aerosol generator and a housing accommodating at least the aerosol generator and the controller, the housing having a base for supporting the housing on a horizontal surface, wherein a portion of the housing accommodating at least a portion of the controller is arranged further away from the base than the aerosol generator as seen in a vertical direction, when the base is supported on the horizontal surface.Type: ApplicationFiled: October 30, 2019Publication date: May 21, 2020Applicant: PARI Pharma GmbHInventors: Tom McPherson Allnutt, Wolfgang Achtzehner, Thomas Gallem, Uwe Hetzer
-
Patent number: 10493217Abstract: Inhalator (50) comprising an aerosol generator (64) configured to generate an aerosol by nebulizing a fluid and a controller (24) configured to control operation of the aerosol generator and a housing (11, 51) accommodating at least the aerosol generator and the controller, the housing having a base (12) for supporting the housing on a horizontal surface, wherein a portion (35) of the housing accommodating at least a portion of the controller is arranged further away from the base than the aerosol generator as seen in a vertical direction, when the base is supported on the horizontal surface.Type: GrantFiled: February 25, 2015Date of Patent: December 3, 2019Assignee: PARI Pharma GmbHInventors: Tom McPherson Allnutt, Wolfgang Achtzehner, Thomas Gallem, Uwe Hetzer
-
Patent number: 10376661Abstract: An opening element for opening an ampoule in an aerosol generation device includes a first member which has a conduit extending therethrough for guiding a fluid contained in the ampoule through the first member and a second member which is arranged at least partly inside or on the conduit. Further, an aerosol generation device includes such an opening element.Type: GrantFiled: September 9, 2013Date of Patent: August 13, 2019Assignee: PARI Pharma GmbHInventors: Thomas Gallem, Uwe Hetzer, Stephen Pham, Reynaldo Quintana
-
Patent number: 10245391Abstract: A fluid reservoir is attachable to an aerosol generation device for guiding a fluid from a fluid container to the aerosol generation device. The fluid reservoir has an interface portion arranged at the fluid reservoir for attaching the fluid reservoir to the aerosol generation device. The interface portion has a locking element configured to non-detachably lock the fluid reservoir to the aerosol generation device after attachment of the fluid reservoir to the aerosol generation device. The locking element is breakable to enable detachment of the fluid reservoir from the aerosol generation device. A combination includes the fluid reservoir and a primary fluid package, wherein the primary fluid package has at least one chamber containing a fluid therein. An aerosol generation device is configured for use with the fluid reservoir has an attachment portion for receiving the interface portion of the fluid reservoir.Type: GrantFiled: November 5, 2013Date of Patent: April 2, 2019Assignee: PARI Pharma GmbHInventors: Thomas Gallem, Uwe Hetzer, Michael Neuner
-
Publication number: 20190038854Abstract: The present invention relates to a medical evaluation device (10) for evaluating an adherence to a therapy protocol when using an aerosol nebulizer (30) having an aerosol generator (31) for nebulizing a liquid medication according to said therapy protocol, said medical evaluation device (10) comprising: a communication unit (100), configured to establish a communication connection with a communication device (20), said communication connection being configured for: providing first configuration data to a nebulizer control device (40) of said aerosol nebulizer (30) via said communication device (20), said first configuration data for configuring said aerosol nebulizer according to said therapy protocol; and receiving nebulizing data indicating an operation of said aerosol nebulizer from said communication device (20); further comprising an evaluation unit (110), configured to evaluate said adherence to said therapy protocol based on a comparison of said received nebulizing data with respective parameters definType: ApplicationFiled: February 8, 2017Publication date: February 7, 2019Applicant: PARI Pharma GmbHInventors: Carola Fuchs, Matthias Finke, Björn Eschrich, Ronald Schmidt
-
Publication number: 20180236478Abstract: An aerosol generator for generating an aerosol from a fluid, comprising: a vibratable membrane having a first side for being in contact with the fluid and an opposite second side, the membrane having a plurality of through holes penetrating the membrane in an extension direction from the first side to the second side, whereby the fluid passes the through holes from the first side to the second side when the membrane is vibrated for generating the aerosol at the second side, each through hole having along its extension direction a smallest diameter, a larger diameter that is larger than the smallest diameter and defined by that diameter that is closest to triple, preferably twice said smallest diameter, each through hole having a nozzle portion defined by that continuous portion of the through hole in the extension direction comprising the smallest diameter of the through hole and bordered by the larger diameter of the through hole, wherein the ratio of the total length of each through hole in the extension diType: ApplicationFiled: April 18, 2018Publication date: August 23, 2018Applicant: PARI Pharma GmbHInventors: Harald Schulz, Philipp Holzmann, Dominique Mutschmann, Michael Hahn
-
Publication number: 20180221906Abstract: The invention relates to a method of manufacturing a vibratable head (1) for an aerosol generator (2), the vibratable head (1) comprising a support member (4), a vibratable membrane (6) supported by the support member (4) and a vibrator (8) configured to vibrate the vibratable membrane (6). The method comprises the steps of providing the support member (4), roughening a surface portion (10) of the support member (4) by laser structuring, applying an adhesive (9) to at least a part of the roughened surface portion (10) of the support member (4) and attaching at least one element to the support member (4) by at least a portion of the adhesive (9). Further, the invention relates to a vibratable head (1) manufactured by this method, an aerosol generator (2) comprising such a vibratable head (1) and a method of manufacturing such an aerosol generator (2).Type: ApplicationFiled: August 3, 2016Publication date: August 9, 2018Applicant: PARI Pharma GmbHInventors: Hans-Lukas Anzenberger, Nicole Brune, Durdica Benko
-
Publication number: 20180178240Abstract: The invention relates to an aerosol generator (1), comprising a housing (20, 22), having a first holding member (24, 24?, 24?) and a second holding member (38), and a vibratable element (4) for generating an aerosol. The vibratable element (4) is at least partially accommodated in the housing (20, 22). The vibratable element (4) is contacted by and held between the first and second holding members (24, 24?, 24?; 38). The first holding member (24, 24?, 24?) is less flexible than the second holding member (38). Further, the invention relates to an aerosol delivery device comprising the aerosol generator (1).Type: ApplicationFiled: June 18, 2015Publication date: June 28, 2018Applicant: PARI Pharma GmbHInventors: Hans-Lukas Anzenberger, Carola Fuchs, Thomas Gallem, Uwe Hetzer, Philipp Holzmann, Gerhard Pumm
-
Publication number: 20180169713Abstract: The invention relates to a method for cleaning a membrane (3) of a membrane aerosol generator (4) of an inhalation therapy device (100), which membrane can vibrate, wherein a cleaning liquid is fed to the membrane (3) and the membrane (3) is caused to vibrate in such a way that the cleaning liquid is conveyed through the openings of the membrane (3), wherein the cleaning liquid contains at least one surfactant. The invention further relates to a combination of a cleaning device (1) and of a cleaning liquid, wherein the cleaning device (1) is designed for cleaning a membrane (3) of a membrane aerosol generator (4) of an inhalation therapy device (100), which membrane can vibrate. The cleaning device (1) comprises a liquid-feeding apparatus (2), which is designed to feed the cleaning liquid to the membrane (3), and a vibration activation apparatus (9), which is designed to activate membrane vibrations such that the cleaning liquid is conveyed through the openings of the membrane (3).Type: ApplicationFiled: January 18, 2016Publication date: June 21, 2018Applicant: PARI PHARMA GmbHInventor: Dominik Müller
-
Patent number: 9975136Abstract: An aerosol generator for generating an aerosol from a fluid, comprising: a vibratable membrane (22) having a first side (24) for being in contact with the fluid and an opposite second side (25), the membrane having a plurality of through holes (26) penetrating the membrane in an extension direction (E) from the first side to the second side, whereby the fluid passes the through holes from the first side to the second side when the membrane is vibrated for generating the aerosol at the second side, each through hole (26) having along its extension direction (E) a smallest diameter (Ds), a larger diameter (DL) that is larger than the smallest diameter and defined by that diameter that is closest to triple, preferably twice said smallest diameter, each through hole having a nozzle portion (32) defined by that continuous portion of the through hole in the extension direction comprising the smallest diameter of the through hole and bordered by the larger diameter of the through hole, characterized in that the ratiType: GrantFiled: June 4, 2012Date of Patent: May 22, 2018Assignee: PARI Pharma GmbHInventors: Harald Schulz, Philipp Holzmann, Dominique Mutschmann, Michael Hahn
-
Publication number: 20180064891Abstract: An inhalation therapy device includes an atomizer for atomizing a drug which is advantageously present in the form of a fluid into an atomization chamber so that an aerosol or mist is provided in the atomization chamber. The patient or user can inhale the aerosol produced by the atomizer from the atomization chamber via a mouthpiece. The ampoule is inserted into an ampoule holder holding the fluid-containing ampoule. The inhalation therapy device also includes an opening unit for opening the fluid-containing ampoule. The ampoule holder advantageously includes a first part, disposed displaceably in relation to the opening unit, thereby allowing an ampoule present in the ampoule holder to be displaced in the direction of the opening unit.Type: ApplicationFiled: September 27, 2017Publication date: March 8, 2018Applicant: PARI Pharma GmbHInventors: Uwe Hetzer, Thomas Gallem
-
Publication number: 20180042988Abstract: The invention relates to cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection. In particular, the invention provides a cyclosporine liquid formulation for use as an aerosol for inhalation in a method of preventing or treating pulmonarychronic graft rejection in single lung transplanted patients. The formulation is preferably administered once or twice daily. The formulation may be aerosolized with a nebulizer that comprises features for monitoring the time, date and duration of inhalation by the patient, in order to monitor patient adherence. The formulation according to the invention may be combined with standard immunosuppressants and corticosteroids.Type: ApplicationFiled: March 15, 2016Publication date: February 15, 2018Applicant: PARI Pharma GmbHInventor: Martin Knoch
-
Publication number: 20170368282Abstract: The invention relates to an aerosol delivery device (10) comprising an aerosol generator (3) for generating an aerosol in the aerosol delivery device (10), a sensor (5) configured to detect a use of the aerosol delivery device (10) for aerosol treatment, and a controller (7) configured to deactivate the aerosol generator (3) if no use of the aerosol delivery device (10) for aerosol treatment is detected by the sensor (5). Further, the invention relates to a method for operating an aerosol delivery device (10), comprising the steps of operating an aerosol generator (3) for generating an aerosol in the aerosol delivery device (10), detecting a use of the aerosol delivery device (10) for aerosol treatment by means of a sensor (5), and deactivating the aerosol generator (3) by means of a controller (7) if no use of the aerosol delivery device (10) for aerosol treatment is detected by the sensor (5).Type: ApplicationFiled: December 17, 2015Publication date: December 28, 2017Applicant: PARI Pharma GmbHInventor: Martin Knoch
-
Patent number: 9789270Abstract: An inhalation therapy device includes an atomizer for atomizing a drug which is advantageously present in the form of a fluid into an atomization chamber so that an aerosol or mist is provided in the atomization chamber. The patient or user can inhale the aerosol produced by the atomizer from the atomization chamber via a mouthpiece. The ampoule is inserted into an ampoule holder holding the fluid-containing ampoule. The inhalation therapy device also includes an opening unit for opening the fluid-containing ampoule. The ampoule holder advantageously includes a first part, disposed displaceably in relation to the opening unit, thereby allowing an ampoule present in the ampoule holder to be displaced in the direction of the opening unit.Type: GrantFiled: August 16, 2006Date of Patent: October 17, 2017Assignee: PARI Pharma GmbHInventors: Uwe Hetzer, Thomas Gallem
-
Patent number: 9744314Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: GrantFiled: August 27, 2014Date of Patent: August 29, 2017Assignee: PARI Pharma GMBHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Publication number: 20170232211Abstract: The invention relates to a fluid reservoir (2) for an aerosol generator (50), the fluid reservoir (2) comprising a fluid chamber (4) for receiving a fluid (6), an opening (8) for guiding the fluid (6) received in the fluid chamber (4) outside the fluid chamber (4), and a collar portion (10) surrounding the opening (8) and extending into the fluid chamber (4). A first portion (12) of the fluid chamber (4) extends along the length of the collar portion (10) in a height direction (H) of the fluid chamber (4), A second portion (14) of the fluid chamber (4) is arranged adjacent to the first portion (12) in the height direction (H) of the fluid chamber (4). A lateral extension of the first portion (12) in the directions perpendicular to the height direction (H) of the fluid chamber (4) is smaller than a lateral extension of the second portion (14) in the directions perpendicular to the height direction (H) of the fluid chamber (4).Type: ApplicationFiled: August 17, 2015Publication date: August 17, 2017Applicant: PARI Pharma GmbHInventors: Thomas Gallem, Uwe Hetzer, Martin Knoch, Michael Neuner
-
Patent number: 9724382Abstract: The invention relates to liquid pharmaceutical compositions containing: a) a therapeutically effective dose of a cyclosporin; b) an aqueous carrier liquid; c) a first solubilizing substance selected among the group of phospholipids; and d) a second solubilizing substance selected among the group of non-ionic surfactants. Preferably, the cyclosporin is liposome solubilized. The inventive composition is suitable for oral, parenteral, nasal, mucosal, topical, and particularly pulmonary application in the form of an aerosol.Type: GrantFiled: December 4, 2012Date of Patent: August 8, 2017Assignee: PARI Pharma GMBHInventors: Manfred Keller, Aslihan Akkar, Ralf Mehrwald